Year |
Citation |
Score |
2019 |
Patsch K, Matasci N, Soundararajan A, Diaz P, Agus DB, Ruderman D, Gross ME. Monitoring dynamic cytotoxic chemotherapy response in castration-resistant prostate cancer using plasma cell-free DNA (cfDNA). Bmc Research Notes. 12: 275. PMID 31092276 DOI: 10.1186/S13104-019-4312-2 |
0.302 |
|
2018 |
Patsch K, Mumenthaler SM, Ruderman D. Image-Based Tracking of Heterogeneous Single-Cell Phenotypes. Methods in Molecular Biology (Clifton, N.J.). 1745: 47-63. PMID 29476462 DOI: 10.1007/978-1-4939-7680-5_3 |
0.335 |
|
2017 |
Patsch K, Soundararajan A, Engeln M, Gross ME, Mumenthaler SM, Ruderman D. Abstract A29: Heterogeneity of androgen receptor dynamics and drug response in prostate cancer cells Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-A29 |
0.32 |
|
2017 |
Shah PP, Patsch K, Matasci N, Soudararajan A, Diaz P, Agus DB, Ruderman D, Gross ME. Abstract 3731: A novel multidimensional cfDNA assay for real time analysis of chemotherapy response Cancer Research. 77: 3731-3731. DOI: 10.1158/1538-7445.Am2017-3731 |
0.326 |
|
2016 |
Patsch K, Chiu CL, Engeln M, Agus DB, Mallick P, Mumenthaler SM, Ruderman D. Single cell dynamic phenotyping. Scientific Reports. 6: 34785. PMID 27708391 DOI: 10.1038/Srep34785 |
0.346 |
|
2012 |
Chambers MC, Maclean B, Burke R, Amodei D, Ruderman DL, Neumann S, Gatto L, Fischer B, Pratt B, Egertson J, Hoff K, Kessner D, Tasman N, Shulman N, Frewen B, et al. A cross-platform toolkit for mass spectrometry and proteomics. Nature Biotechnology. 30: 918-20. PMID 23051804 DOI: 10.1038/Nbt.2377 |
0.514 |
|
1994 |
Ruderman DL, Bialek W. Statistics of natural images: Scaling in the woods. Physical Review Letters. 73: 814-817. PMID 10057546 DOI: 10.1103/PhysRevLett.73.814 |
0.433 |
|
1992 |
Ruderman DL, Bialek W. Seeing Beyond the Nyquist Limit Neural Computation. 4: 682-690. DOI: 10.1162/neco.1992.4.5.682 |
0.434 |
|
Show low-probability matches. |